Role of sentinel lymph node dissection in breast cancer

References

• National Institutes of Health. NIH consensus conference on the treatment of early-stage breast cancer. JAMA 1991; 265: 391–5
   PubMedGoogle Scholar
• Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981; 152: 765–72
   PubMedGoogle Scholar
• De Freitas R, Jr, Costa M V, Schneider S V. Accuracy of ultrasound and clinical examination in the diagnosis of axillary lymph node metastases in breast cancer. Eur J Surg Oncol 1991; 17: 240–4
   Google Scholar
• Noguchi M, Ohta N, Thomas M, Kitagawa H, Earashi M, Miyazaki I, et al. Clinical and biological prediction of axillary and internal mammary lymph node metastases in breast cancer. Surg Oncol 1993; 2: 51–8
   PubMedGoogle Scholar
• Ball A B, Waters R, Fish S, Thomas J M. Radical axillary dissection in the staging and treatment of breast cancer. Ann R Coll Surg Engl 1992; 74: 126–9
   Google Scholar
• Nieweg O E, Kim E E, Wong W H, Broussard W F, Singletary S E, Hortobagyi G N, et al. Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer. Cancer 1993; 71: 3920–5
   Google Scholar
• Davies G C, Millis R R, Hayward J L. Assessment of axillary lymph node status. Ann Surg 1980; 192: 148–51
   PubMed Web of Science ®Google Scholar
• Halverson K J, Taylor M E, Perez C A, Garcia D M, Myerson R, Philpott G, et al. Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer. Int J Radiat Oncol Biol Phys 1993; 26: 593–9
   PubMedGoogle Scholar
• Recht A, Pierce S M, Abner A, Vicini F, Osteen R T, Love S M, et al. Regional node failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 1991; 9: 988–96
   PubMed Web of Science ®Google Scholar
• Keramopoulos A, Tsionou C, Minaretzis D, Michalas S, Aravantinos D. Arm morbidity following treatment of breast cancer with total axillary dissection: a multivariated approach. Oncology 1993; 50: 445–9
   PubMed Web of Science ®Google Scholar
• Ivens D, Hoe A L, Podd T J, Hamilton C R, Taylor I, Royle G T. Assessment of morbidity from complete axillary dissection. Br J Cancer 1992; 66: 136–8
   PubMed Web of Science ®Google Scholar
• Larson D, Weinstein M, Goldberg I, Silver B, Recht A, Cady B, et al. Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 1986; 12: 1575–82
   PubMed Web of Science ®Google Scholar
• Parmigiani G, Berry D A, Winer E P, Tebaldi C, Iglehart J D, Prosnitz L R. Is axillary lymph node dissection indicated for early-stage breast cancer? A decision analysis. J Clin Oncol 1999; 17: 1465–73
   Google Scholar
• Cady B, Stone M D, Schuler J G, Thakur R, Wanner M A, Lavin F T. The new era in breast cancer: invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 1996; 131: 301–8
   PubMedGoogle Scholar
• Silverstein M J, Gierson E D, Waisman J R, Senofsky G M, Colburn W J, Gamagami P, et al. Axillary lymph node dissection for T1a breast carcinoma. Is it indicated. Cancer 1994; 73: 664–7
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992; 339: 1–15
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992; 339: 71–85
   PubMed Web of Science ®Google Scholar
• Jamali F R, Kurtzman S H, Deckers P J. Role of axillary dissection in mammographically detected breast cancer. Surg Oncol Clin North Am 1997; 6: 343–58
   Google Scholar
• Cabanas R M. An approach for the treatment of penile carcinoma. Cancer 1977; 39: 456–66
   PubMed Web of Science ®Google Scholar
• Morton D L, Wen D R, Wong J H, Economou J S, Cagle L A, Storm F K. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392–9
   PubMed Web of Science ®Google Scholar
• Giuliano A E, Kirgan D M, Guenther J M, Morton D L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391–401
   PubMed Web of Science ®Google Scholar
• Giuliano A E, Jones R C, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15: 2345–50
   PubMed Web of Science ®Google Scholar
• Giuliano A E, Dale P S, Turner R R, Morton D L, Evans S W, Krasne D L. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 222: 394–401
   PubMed Web of Science ®Google Scholar
• Guenther J M, Krishnamoorthy M, Tan L R. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 1997; 3: 336–40
   Web of Science ®Google Scholar
• Koller M, Barsuk D, Zippel D, Engelberg S, Ben-Ari G, Papa M Z. Sentinel lymph node involvement - a predictor for axillary node status with breast cancer - has the time come. Eur J Surg Oncol 1998; 24: 166–8
   PubMed Web of Science ®Google Scholar
• Flett M M, Going J J, Stanton P D, Cooke T G. Sentinel node localization in patients with breast cancer. Br J Surg 1998; 85: 991–3
   Google Scholar
• Dale P S, Williams J T. 4th. Axillary staging utilizing selective sentinel lymphadenectomy for patients with invasive breast carcinoma. Am Surg 1998; 64: 28–32
   Google Scholar
• Krag D N, Weaver D L, Alex J C, Fairbank J T. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2: 335–9
   PubMed Web of Science ®Google Scholar
• Veronesi U, Paganelli G, Galimberti V, Vide G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349: 1864–7
   PubMed Web of Science ®Google Scholar
• Pijpers R, Meijer S, Hoekstra O S, Collet G J, Comans E FI, Boom R PA, et al. Impact of lymphoscintigraphy on sentinel node identification with Technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1997; 38: 366–8
   PubMed Web of Science ®Google Scholar
• Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg V S, Shriver C, et al. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med 1998; 339: 941–6
   PubMed Web of Science ®Google Scholar
• Borgstein P J, Pijpers R, Comans E F, van Diest P J, Boom R P, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186: 275–83
   PubMed Web of Science ®Google Scholar
• Crossin J A, Johnson A C, Stewart P B, Turner W W, Jr. Gamma-probe-guided resection of the sentinel lymph node in breast cancer. Am Surg 1998; 64: 666–9
   PubMed Web of Science ®Google Scholar
• Miner T J, Shriver C D, Jaques D P, Maniscalco-Theberge M E, Krag D N. Ultrasonographically guided injection improves localization of the radiolabeled sentinel lymph node in breast cancer. Ann Surg Oncol 1998; 5: 315–21
   Google Scholar
• Offodile R, Hoh C, Barsky S H, Nelson S D, Elashoff R, Eilber F R, et al. Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran. Cancer 1998; 82: 1704–8
   Google Scholar
• De Cicco C, Cremonesi M, Luini A, Bartolomei M, Grana C, Prisco G, et al. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med 1998; 12: 2080–4
   Google Scholar
• Cox C E, Pendas S, Cox J M, Joseph E, Shons A R, Yeatman T, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998; 227: 645–53
   PubMed Web of Science ®Google Scholar
• Albertini J J, Lyman G H, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276: 1818–22
   PubMed Web of Science ®Google Scholar
• Borgstein P J, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymphnode in breast cancer. Lancet 1997; 349: 1668–9
   PubMed Web of Science ®Google Scholar
• O'Hea B J, Hill A DK, El-Shirbiny A M, Yeh S DJ, Rosen P P, Coit D G, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998; 186: 423–7
   PubMed Web of Science ®Google Scholar
• Barnwell J M, Arredondo M A, Kollmorgen D, Gibbs J F, Lamonica D, Carson W, et al. Sentinel node biopsy in breast cancer. Ann Surg Oncol 1998; 5: 126–30
   PubMed Web of Science ®Google Scholar
• Turner R R, Ollila D W, Krasne D L, Giuliano A E. Histopathological validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997; 226: 271–8
   PubMed Web of Science ®Google Scholar
• Liberman L, Vuolo M, Dershaw D D, Morris E A, Abramson A F, La Trenta L R, et al. Epithelial displacement after stereo-tactic 11-gauge directional vacuum-assisted breast biopsy. AJR Am J Roentgenol 1999; 172: 677–81
   Google Scholar
• Haigh P I, Hansen N M, Qi K, Giuliano A E. Method of biopsy and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol, (in press)
   Google Scholar
• van der Ent F WC, Kengen R AM, van der Pol H AG, Hoofwijk A GM. Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer. Eur J Surg Oncol 1999; 25: 24–9
   PubMedGoogle Scholar
• Lacour J, Le M, Caceres E, Koszarowski T, Veronesi U, Hill C. Radical mastectomy versus radical mastectomy plus internal mammary dissection: ten year results of an international cooperative trial in breast cancer. Cancer 1983; 51: 1941–3
   Google Scholar
• Veronesi U, Cascinelli N, Greco M, Bufalino R, Morabito A, Galluzzo D, et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 1985; 202: 702–7
   PubMed Web of Science ®Google Scholar
• Veronesi U, Valagussa P. Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer 1981; 47: 170–5
   PubMed Web of Science ®Google Scholar
• Chu K U, Turner R R, Hansen N M, Brennan M B, Bilchik A, Giuliano A E. Do all patients with sentinel node metastases need complete axillary node dissection. Ann Surg 1999; 229: 536–41
   PubMed Web of Science ®Google Scholar